Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Results of a Ivor-Lewis Operation for Esophageal Squamous Cell Carcinoma

식도 편평세포암에시 Ivor-Lewis수술 성적

  • Cho, Seong-Ho (Department of Thoracic and Cardiovascular Surgery, Kosin University College of Medicine) ;
  • Kim, Jong-In (Department of Thoracic and Cardiovascular Surgery, Kosin University College of Medicine) ;
  • Cho, Sung-Rae (Department of Thoracic and Cardiovascular Surgery, Kosin University College of Medicine)
  • 조성호 (고신대학교 의과대학 복음병원 흉부외과학교실) ;
  • 김종인 (고신대학교 의과대학 복음병원 흉부외과학교실) ;
  • 조성래 (고신대학교 의과대학 복음병원 흉부외과학교실)
  • Published : 2007.12.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The Ivor-Lewis operation has been widely applied for treating thoracic esophageal cancer, but more acceptable results from three-field lymph node dissection have recently been reported. In this study the efficacy of the Ivor-Lewis operation was evaluated. Material and Method: Among the 273 patients, who underwent operation for esophageal cancer between September 1994 and August 2004, we retrospectively studied 172 patients with esophageal squamous cell carcinoma and who had no other primary cancer and who underwent complete resection with an Ivor-Lewis operation. The postoperative complications, the short and long-term survival and the recurrence patterns were analyzed. Result: The postoperative staging was as follows: stage I in 40 cases, IIA in 48 cases, IIB in 18 cases, III in 55 cases, IVA in 5 cases and IVB in 6 cases. The operative mortality rate was 4% (7 of 172 pts). Postoperative complication occurred in 32 patients (18%) and tumor recurred in 55 patients (32%). The overall 5-year survival rate was 48%; it was 85.6% in stage I patients, 47.6% in IIA patients, 65% in IIB patients, 22.8% in III patients and 0% for those in IV (p<0.05). The 5-year survival rate according to the location of esophageal cancer was 26.5% for patients with tumor in the upper 1/3 of the esophagus and 52.4% for patients with tumor in the mid and lower 1/3 (p>0.05). Conclusion: The Ivor-Lewis operation is an acceptable surgical procedure for thoracic esophageal squamous cell carcinoma. Yet it is necessary to consider other surgical procedures, and especially three-field lymph node dissection for treating upper 1/3 esophageal cancer.

배경: 흉부 식도암에서 Ivor-Lewis수술이 널리 이용되어 왔으나 최근 3구역 절제술로 보다 좋은 성적들이 보고되고 있다. 식도 편평세포암 환자에서 Ivor-Lewis수술의 유용성을 알아보고자 한다. 대상 및 방법: 1994년 9월부터 2004년 8월까지 식도암으로 절제술을 받은 273명의 환자 중 편평세포암으로 다른 원발성 암이 없고 Ivor-Lewis수술로 완전절제가 가능하였던 172명을 대상으로 술 후 합병증, 조기 및 장기성적, 재발양상을 후향적인 방법으로 분석하였다. 결과: 술 후 병기는 I기 40명(23%), IIA기 48명(27%), IIB기 18명 (10%), III기 55명(33%), IVA 5명(3%), IVB 6명(4%)이었다. 수술과 관련된 사망은 172명의 환자 중 7명(4%)에서 발생하였으며 술 후 합병증은 32명(18%)에서 발생하였고 55명(32%)에서 재발하였다. 전체 환자의 5년 생존율은 48%였는데, 병기별 5년 생존율은 I기 85.6%, IIA기 47.6%, IIB기 65%, III기 22.8%, IV기 0%였다. 종양의 위치에 따른 5년 생존율은 상흉부가 26.5%로 중흉부와 하흉부 52.4%에 비해 낮았으나 통계적 유의성은 없었다. 결론: 이상의 결과로 식도 편평세포암 환자에서 Ivor-Lewis수술의 적용은 비교적 만족할 만한 결과를 얻었으며, 상흉부 식도암인 경우에는 통계적 유의성은 없었으나 중 하 흉부식도암에 비해 낮은 5년 생존율을 보여 3구역 림프절절제술로의 전환도 고려해야 할 것으로 생각된다.

Keywords

References

  1. O'Pourke I, Tait N, Mull C, Gebski V, Holland M, Johnson DC. Oesophageal cancer: Outcome of modern surgical management. Aust N Z J Surg 1995;65:11-6 https://doi.org/10.1111/j.1445-2197.1995.tb01739.x
  2. Wenz F, Mamon H. Perioperative radiotherapy for cancer of the esophagus. Semin Surg Oncol 2001;20:33-9 https://doi.org/10.1002/ssu.1014
  3. Bains MS, Stojadinovic A, Minsky B. A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results. J Thorc Cardiovasc Surg 2002;124:270-7 https://doi.org/10.1067/mtc.2002.122545
  4. Masahiko T, Yoshiaki K, Haruchi U, Hiroshi A. Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovasc Surg 2001;7:325-9
  5. King RM, Pairolero PC, Trastek VF, Payne WS, Bernatz PE. Ivor Lewis esophagectomy for carcinoma of the esophagus: early and late functional results. Ann Thorac Surgery 1987;44:119-22 https://doi.org/10.1016/S0003-4975(10)62019-X
  6. Muller JM, Erasmi H, Stelzner M. Surgical therapy of oesophageal carcinoma. Br J Surg 1990;77:845-57 https://doi.org/10.1002/bjs.1800770804
  7. Orringer MB. Transhiatal esophagectomy without thoracostomy for carcinoma of the thoracic esophagus. Ann Surg 1984;200:282-7 https://doi.org/10.1097/00000658-198409000-00005
  8. Mitsuo T, Shoichi K, Hiroshi Y, Muneaski S, Yasuhito T. Clinical outcomes of extended esophagectomy with threefield lymph node dissection for esophageal squamous cell carcinoma. Am J Surg 2005;189:98-109 https://doi.org/10.1016/j.amjsurg.2004.10.001
  9. Shin HJ, Kim CW, Park SI, Kim YH, Kim DK, Park SI. Anastomotic leakage and stricture relating to anastomotic level and methods in esophageal resection and reconstruction for esophageal cancer. Korean J Thorac Cardiovasc Surg 2006;39:208-13
  10. Lee JH, Lee JC. Pulmonary complication after surgery for esophageal cancer. Korean J Thorac Cardiovasc Surg 2006;39:134-9
  11. Fergueson MK, Durkin AE. Preoperative prediction of the risk of pulmonary complication after esophagectomy for cancer. J Thorac Cardiovasc Surg 2002;123:661-9 https://doi.org/10.1067/mtc.2002.120350
  12. Visbal AL, Allen MS, Miller DL, Trastek VF, Pairolero PC. Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg 2001;71:1803-8 https://doi.org/10.1016/S0003-4975(01)02601-7
  13. Fujita H, Kakegawa T. Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer: a comparision for three-field lymphadenectomy with 2-field lymphadenectomy. Ann Surg 1995;222:654-62 https://doi.org/10.1097/00000658-199511000-00008
  14. Sato N, Koeda K, Ikeda K, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 2002;236:184-90 https://doi.org/10.1097/00000658-200208000-00006
  15. Law SYK, Fok M, Wong J. Pattern of recurrence after oesophageal resection for cancer: clinical implication. Br J Surg 1996;83:107-11 https://doi.org/10.1002/bjs.1800830134
  16. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994;220:364-72 https://doi.org/10.1097/00000658-199409000-00012
  17. Kim YT, Sung SW, Kim JH. Long term survival after the resection of esophageal cancer. Korean J Thorac Cardiovasc Surg 1999;32:653-9
  18. Yim SB, Park JH, Baik HJ. Long term result of surgical treatment for esophageal cancer. Korean J Thorac Cardiovasc Surg 2001;34:148-55